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Abstract
Background: While it is known that irradiation can induce local and systemic bone loss over time, how focal
irradiation induces systemic bone complications remains unclear. Immune cells are thought to be crucial to
bone homeostasis, and abnormal immune cells lead to serious disruption of bone homeostasis, such as in acute
lymphoblastic leukaemia. This disruption primarily occurs due to inhibition of the osteogenic differentiation of
bone mesenchymal stem cells (BMSCs).
Methods: In this study, we detected local and systemic bone loss in trabecular bone by micro-computed
tomography (micro-CT) and measurement of peroxisome proliferator-activated receptor gamma (PPARγ) and
runt-related transcription factor 2 (RUNX2) expression in BMSCs using real-time polymerase chain reaction and
western blotting. Additionally, changes in lymphocytes (B cells and CD4+ and CD8+ T cells) in the peripheral
blood and bone marrow were analysed by flow cytometry. BMSC-derived osteoblasts and adipocytes, cultured
in osteogenic or adipogenic media or co-cultured with lymphocytes, were detected by BCIP/NBT, Alizarin
Red S and Oil Red O staining.
Results: Focal irradiation induced local and systemic bone loss in trabecular bone. Increased PPARγ expression
and decreased RUNX2 expression were observed, accompanied by upregulated adipogenesis and downregulated
osteogenesis of BMSCs. B cells and CD8+ T lymphocytes were increased in the blood and bone marrow after
irradiation, while CD4+ T lymphocytes were decreased in the blood. Inhibition of RUNX2 expression and
reduction of alkaline phosphatase activity and mineralization deposits were observed in lymphocyte-co-cultured
BMSCs, accompanied by an increase in PPARγ expression and in the number of lipid droplets.
Conclusions: Focal irradiation induced local and systemic bone loss in trabecular bone. Increased B cells and
CD8+ T lymphocytes led to systemic bone loss by decreasing BMSC osteogenesis.
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Background
Radiotherapy is an effective anti-cancer strategy combined
with surgery and/or chemotherapy and reduces mortality
rates [1]. However, radiotherapy also reduces patient
quality of life, and long-term side effects of radiotherapy,
such as bone complications, begin to emerge in cancer
survivors. Specifically, the incidence of bone complica-
tions at irradiated sites increases after radiotherapy [2–8].
In addition to the direct effects of radiation on bone, bone
complications, including bone fracture, occur outside of
irradiated sites [9–13]. However, the mechanism by which
systemic bone complications occur after a single irradi-
ation treatment has not been elucidated. Some researchers
have suggested that oxidative stress affects bone after
irradiation, while others hypothesized that inflamma-
tory factors induce bone loss after radiation. However,
few reports discuss changes in immune cells and their
relation to systemic bone loss after a single dose of
irradiation.
Recent observations that abnormal activation of the
immune system can lead to bone destruction and that
mice deficient in immunomodulatory molecules often
develop an unexpected skeletal phenotype [14–16] have
led to the view that there is a close relationship between
the bone and immune systems, particularly under patho-
logical conditions [17]. Irradiated areas have damage to
almost all tissues (from the skin through to the bone
marrow), including local bone and immune cells. Unlike
surgery, which generally leads to full recovery, radiation
damage lasts for the rest of the patient’s life and may be
a source of abnormally activated immune cells that alter
bone metabolism.
Here, we used a rat model of focal irradiation to detect
changes in microarchitectural structures of bone and B
and T lymphocytes in the blood and bone marrow
12 weeks post-irradiation. We also investigated the poten-
tial of bone mesenchymal stem cells (BMSCs) to differen-
tiate into osteoblasts and adipocytes after irradiation and
observed the effects of lymphocytes from irradiated rats
on the differentiation of BMSCs.
Methods
Animal treatment
Four-month-old male Sprague-Dawley rats (Shanghai
Lab Animal Resource Centre, STCSM, Shanghai, China)
were used for the experiments. Rats in the irradiated
group (n = 40) were anaesthetized with ketamine, placed
in a 137Cs γ-ray irradiation chamber (MDS Nordion
International, Kanata, Canada), and exposed to 20 Gy
(0.8 Gy/min for 25 min, 137Cs γ-ray irradiation machine)
on the right limb in a 2-cm by 2-cm area covering the
proximal tibia and distal femur. Unirradiated body parts,
including the skeleton, were shielded with a custom-
made lead block, and contralateral sides of the femur
and tibia (the bone that did not receive radiation but
was removed from irradiated rats) represented areas dis-
tant from irradiation. Control rats (n = 40) were similarly
manipulated, anaesthetized, and subjected to sham ir-
radiation (0 Gy). All experiments involving animals were
performed according to institutionally approved and
current animal care guidelines.
Micro-CT analysis
Micro-computed tomography (CT) analysis of the tibia was
conducted using a SkyScan-1176 micro-CT (μCT, Bruker
micro-CT, Kontich, Belgium) system. Scans were performed
using a PANalytical Microfocus Tube (17.93-μm voxel size,
65 KV, 385 μA, 0.5-degree rotation step, and 180-degree
angular range). Micro-CT evaluation of the trabecular bone
was performed on a 2-mm region of metaphyseal spongiosa
in the proximal tibia located 0.5 mm above the growth
plate. Measurements of the cortical bone were performed
on a 1-mm region of the mid-diaphysis of the tibia. NRecon
software version 1.6 (Bruker) was used for 3D reconstruc-
tion and to view images. After 3D reconstruction, CT
software version 1.13 (Bruker) was used for bone analysis.
Histological examination and histomorphometry
Tibia sections were stained with Oil Red O and Mayer’s
haematoxylin and histochemically tested for alkaline phos-
phatase (ALP) activity using a BCIP/NBT kit (Beyotime
Biotechnology, Jiangsu, China) and for tartrate-resistant
acid phosphatase (TRAP) activity using a TRACP kit
(Sigma-Aldrich, St. Louis, MO, USA). The sections were
then counterstained with methyl green and mounted in
Kaiser's glycerol jelly. The following parameters were
measured: the ALP-positive osteoblast surface per bone
surface (OB.S/BS, %) for bone formation, the TRAP-
positive osteoclast surface per bone surface (OC.S/BS, %)
for bone resorption, and the adipocyte area per bone mar-
row area without trabecula (%) for marrow adiposity [18].
Images of micrographs from single sections were digitally
recorded using a rectangular template, and recordings
were processed and analysed using Image-Pro Plus image
analysis software (Image-Pro Plus, version 4.112, Media
Cybernetics, LP, Silver Spring, MD, USA).
Measurement of bone turnover markers in serum by ELISA
Blood was collected at 12 weeks post-irradiation. Serum
from each rat was analysed individually in duplicate for
the bone formation marker osteocalcin (OCN) using a Rat
Osteocalcin EIA kit (Immunodiagnostic Systems Inc.,
Boldon, UK) according to the manufacturer’s instructions.
Bone resorption was examined with the marker TRAP 5b
(TRAP5b) using a Rat TRAP Assay (Immunodiagnostic
Systems Inc.) according to the manufacturer’s instructions.
The average value of the duplicate measurements was
obtained for each rat.
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Flow cytometry
Blood and bone marrow were collected 12 weeks after
radiation. Cells were incubated with anti-rat CD3-FITC/
CD45RA-PC7 and anti-rat CD3-FITC/CD4-PC7/CD8-
APC (Beckman Coulter, High Wycombe, UK) at room
temperature for 20 min, then with OptiLyse C (Beckman
Coulter, UK) at room temperature for 10 min. The cells
were then washed twice with phosphate-buffered saline
(PBS) and resuspended in 500 μl PBS. All samples were
assessed by flow cytometry (Beckman Coulter, Brea, CA,
USA). The percentage of cells was based on the evalu-
ation of 100,000 events for each culture condition [19].
Cell culture
BMSCs were flushed from the tibia and femur 12 weeks
after irradiation with a-MEM (Gibco BRL, Carlsbad, CA,
USA). The cells were seeded on 100-mm culture dishes
(Nunc, Rochester, NY, USA) and cultured in L-DMEM
supplemented with 100 IU/ml penicillin, 100 mg/ml
streptomycin (Gibco BRL), and 10% foetal bovine serum
(FBS, Gibco BRL). The media was replaced every 3–4 days
to remove non-adherent haematopoietic cells. After
2 weeks, the adherent cells were collected and sorted by
flow cytometry with CD29, CD90, and CD34. The sorted
BMSCs (CD29+, CD90+, and CD34-) were cultured in
fresh medium and further subcultured. The first passage
of sorted BMSCs was termed passage 1. BMSCs between
passages 3 and 5 were used for experiments. To induce
osteogenic differentiation, passage 4 BMSCs were cultured
with a-MEM supplemented with 10% FBS, ascorbic acid
(50 mg/ml), and b-glycerophosphate (10 mM) for up to
14 days (for ALP staining) or 28 days (for Alizarin Red
staining). Adipogenic differentiation was induced by cul-
turing with insulin (10 mg/ml), dexamethasone (1 mM),
and 3-isobutyl-1-methylxanthine (0.5 mM) for up to
21 days (for Oil Red O staining).
Co-culture
Bone marrow mononuclear cells were isolated by density
gradient centrifugation (lymphocyte separation medium,
Sigma-Aldrich) within 6 h of sampling. Adherent cells
were removed using plastic adherent culture dishes, and
the remaining cells were immediately co-cultured with
normal BMSCs for 3 days. Some samples were used for
real-time PCR and western blotting; others were cultured
with a-MEM supplemented with 10% FBS, ascorbic acid
(50 mg/ml), and b-glycerophosphate (10 mM) for up to
14 days (for ALP staining) and 28 days (for Alizarin Red
staining) to induce osteogenic differentiation. Adipogenic
differentiation was induced by culturing with insulin
(10 mg/ml), dexamethasone (1 mM), and 3-isobutyl-1-
methylxanthine (0.5 mM) for up to 21 days (for Oil Red O
staining).
Quantitative real-time PCR
Cultured and co-cultured BMSCs were collected, and total
ribonucleic acid (RNA) was extracted using TRIzol re-
agent (15596; Invitrogen, Carlsbad, CA, USA) according
to the manufacturer’s protocol. Total RNA was reverse-
transcribed to cDNA using QuantiTect Rev Transcription
kits (205311; Qiagen, Chatsworth, CA, USA). The number
of cDNA molecules in the reverse-transcribed samples was
determined using a modified real-time PCR method with
QuantiTect SYBR Green PCR kits (204143, Qiagen) on a
Mx3000P Real-Time PCR system (Stratagene, La Jolla,
CA, USA). Primers with the following sequences were
obtained from SBS Genetech (http://www.sbsbio.com/
news/englishnew/index.php) using a previously described
protocol: RUNX2, 5'-AGCCTCTTCAGCGCAGTGAC-3'
and 5'-CTGGTGCTCGGATCCCAA-3' (132 bp, AF187319);
PPARγ, 5'-TCAGGTTTGGGCGAATGC-3' and 5'-TTTGG
TCAGCGGGAAGGA3' (152 bp, Nm013124.3); and GAP
DH, 5'-AAACCCATCACCATCTTCCA-3' and 5'-GTGGTT
CACACCCATCACAA-3' (198 bp, DQ403053) [17].
The PCR reactions included 12.5 μl of Master SYBR
Green I, 0.25 μM of each 5' and 3' primer, and 2 μl of sam-
ples and/or H2O in a final volume of 25 μl. A melting
curve was obtained at the end of each run to discriminate
specific from nonspecific cDNA products. The cDNA
content was normalized by subtracting the cycle numbers
of GAPDH from those of the target gene (ΔCt = Ct of
target gene – Ct of GAPDH), and gene expression levels
were calculated using the 2–(ΔCt) method [20].
Western blotting analysis
Cultured and co-cultured BMSCs were collected and
lysed with radioimmunoprecipitation assay (RIPA) buf-
fer (P0013B; Beyotime Biotechnology, Jiangsu, China).
Cells were extracted for 20 min on ice. Insoluble mate-
rials were removed by centrifuging at 12,000 g for
30 min. Supernatants were collected, and protein levels
were quantified using a bicinchoninic acid assay (BCA)
(P0012, Beyotime Biotechnology); bovine serum albumin
(BSA) was used as a standard. The sample protein was de-
natured in boiling water for 5 min in SDS-PAGE sample
loading buffer (P0015, Beyotime Biotechnology). Aliquots
of samples (40 μg) were then subjected to SDS-PAGE in
12% gels under reducing conditions and electroblotted
onto PVDF membranes (Ipvh00010; EMD Millipore,
Bedford, MA, USA). The membranes were blocked with
5% fat-free dry milk in Tris-buffered saline and Tween 20
(TBST) (0.1% Tween-20 and 0.1 M NaCl in 0.1 M Tris–
HCl, pH 7.5) for 2 h at room temperature. Then, the
membranes were incubated at 4 °C overnight with a
goat anti-RUNX2 antibody (1:500; ab56326; Abcam,
Cambridge, MA, USA), a rabbit anti-PPARγ antibody
(1:1500; AT819, Beyotime Biotechnology), or a mouse
anti-GAPDH antibody (1:5000; Kangcheng Biotechnology
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Inc., Shanghai, China). The membranes were then incu-
bated with a horseradish peroxidase-conjugated secondary
antibody (1:5000; Santa Cruz Biotechnology, Dallas, TX,
USA) at room temperature for 1 h, followed by chemilu-
minescence detection (P0018, Beyotime Biotechnology).
Each incubation step was followed by three washes
(10 min each) with TBST. Protein bands were quantita-
tively analysed using an image analysis system (Quanti-
tyOne software; Bio-Rad, Hercules, CA, USA) [20]
Statistical analysis
Differences were determined by one-way ANOVA with
Bonferroni post hoc testing or by paired or unpaired
Student’s t test, as appropriate (GraphPad Prism 6,
version 6.0c, GraphPad Software, San Diego, CA, USA).
The results were expressed as the means ± standard deri-
vations, and P < 0.05 was considered significant.
Results
Bone microarchitecture is changed after a single dose of
radiation
We used μCT to delineate a purely trabecular region of
interest that showed changes in bone volume and micro-
architectural structure. Twelve weeks post-irradiation
(20 Gy), trabecula bone mineral density (tBMD) was re-
duced by 19.9% (P < 0.05) in the contralateral tibia and
Fig. 1 Effects of in vivo radiation exposure to a single bone on trabecular and cortical bone of the tibia 12 weeks post-irradiation. a, b Representative
reconstructed images of μCT scans showing trabecular and cortical bone in the tibia and (c) tBMD. Differences in (d) BV/TV, (e) BS/BV, (f) Tb.Th, (g)
Tb.N, (h) Ct.Th, (i) cortical porosity, and (j) Ct.Ar./Tt.Ar. Data are presented as the means ± standard deviations; *P < 0.05 and **P < 0.01 (n = 16/group).
BS/BV ratio of bone surface to the bone volume, BV/TV bone volume fraction, ratio of the segmented bone volume to the total volume of the region
of the region of interest, CT computed tomography, Ct.Ar./Tt.Ar cortical area fraction, Ct.Th average cortical thickness, Tb.N trabecular number, measure
of the average number of trabeculae per unit length, Tb/Th trabecular thickness, mean thickness of trabeculae, tBMD trabecular bone mineral density
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by 24.4% (P < 0.05) in the irradiated tibia relative to the
control tibia (Fig. 1a and c). The trabecular bone volume
(BV/TV) was reduced by 21.0% (P < 0.05) in the contra-
lateral tibia and by 24.8% (P < 0.05) in the irradiated tibia
relative to the control tibia (Fig. 1d). Bone surface to
bone volume (BS/BV) ratio was increased by 15.1% (P <
0.05) in the contralateral tibia and by 16.9% (P < 0.05) in
the irradiated tibia compared with the control tibia
(Fig. 1e). Trabecular thickness (Tb.Th) and trabecular
number (Tb.N) were significantly reduced at 12 weeks
after irradiation. Tb.Th was reduced by 7.6% (P < 0.05)
in the contralateral tibia and by 11.1% (P < 0.05) in the
irradiated tibia compared with the control tibia. Mean-
while, Tb.N was reduced by 15.8% (P < 0.05) in the
contralateral tibia and by 16.5% (P < 0.05) in the irradi-
ated tibia relative to the control tibia (Fig. 1f and g). The
bone microarchitecture of the cortical tibia changed only
slightly, and no significant differences were observed
(Fig. 1b). However, cortical porosity increased by 39.3%
(P < 0.05) and 96.4% (P < 0.01) in the contralateral and
irradiated tibias, respectively, relative to the control tib-
ias (Fig. 1i).
Decreased osteoblastogenesis and an increase in
adipocytes after a single dose of radiation
To examine changes in osteoblast and osteoclast activity,
histomorphometric analysis was performed on ALP- and
TRAP-stained sections. The results showed that the
ALP-positive osteoblast surface to bone surface (OB.S/
BS) decreased by 51.7% (P < 0.01) and 50.8% (P < 0.01) in
the contralateral and irradiated tibias, respectively, rela-
tive to the control tibias at 12 weeks after irradiation
(Fig. 2a). At this time point, there was no difference in
the ratio of TRAP-positive osteoclast surface to bone
surface (OC.S/BS) between the two groups (Fig. 2b).
ELISA analysis of bone turnover markers in the serum
revealed a 29.9% (P < 0.05) reduction in OCN at
12 weeks post-irradiation (Fig. 2d); the serum bone re-
sorption marker TRAP5b also tended to be reduced
(16.7%, P > 0.05) (Fig. 2d). The adipocyte area in the
bone marrow of the contralateral and irradiated tibias
increased significantly after irradiation, with an increase
of 92.6% (P < 0.01) in the contralateral tibias and
129.6% (P < 0.001) in the irradiated tibias at 12 weeks
(Fig. 2c).
Fig. 2 Effects of in vivo radiation exposure to a single bone. a ALP-stained sections showing effect on OB.S/BS at 12 weeks. b TRAP-stained sections
showing effect on OC.S/BS at 12 weeks. c Oil Red O-stained sections showing effect on adipocyte area. Data are presented as the means ± standard
deviations; **P < 0.01 and ***P < 0.001 (n = 8/group). d Levels of serum OCN and TRAP at 12 weeks. Data are presented as the means ± standard
deviations; *P < 0.05 (n = 16/group). ALP alkaline phosphatase, OB.S/BS osteoblast surface to bone surface, OC.S/BS TRAP-positive osteoclast surface to
bone surface, OCN osteocalcin, TRAP tartrate-resistant acid phosphatase
Xu et al. Stem Cell Research & Therapy  (2017) 8:71 Page 5 of 11
Increasing adipocyte and decreasing osteoblast
differentiation of BMSCs in vitro after a single irradiation
To evaluate the influence of a single irradiation dose on
osteoblast/adipocyte differentiation from progenitors, in-
duction cultures of BMSCs were performed. Determination
of differentiation was based on a sharp increase in adipo-
cytes and decrease in osteoblasts in bone marrow after
irradiation. ALP staining demonstrated that osteoblast dif-
ferentiation was markedly decreased in cultures from
contralateral and irradiated sites relative to controls, and
Alizarin Red staining showed the same trend. However, Oil
Red O staining increased, demonstrating that adipocyte dif-
ferentiation was increased after irradiation in cultures from
both irradiated and contralateral sites (Fig. 3a).
The expression levels of runt-related transcription
factor 2 (RUNX2) and peroxisome proliferator-activated
receptor gamma (PPARγ) were determined in BMSCs at
12 weeks after irradiation by real-time PCR and western
blotting. There was a significant decrease in RUNX2
mRNA (-44.1% at contralateral sites, P < 0.05, and -94.5%
at irradiated sites, P < 0.001) (Fig. 3b). However, PPARγ
expression was markedly upregulated by approximately
9-fold (P < 0.001) in contralateral bone and by 13-fold
(P < 0.001) in irradiated bone relative to controls (Fig. 3c).
Therefore, the ratio of RUNX2 to PPARγ decreased
sharply, with a 93.9% (P < 0.001) reduction in contralateral
bone and a 99.0% (P < 0.001) reduction in irradiated bone
(Fig. 3d). Similar to the corresponding mRNA levels,
RUNX2 and PPARγ protein levels were altered at 12 weeks
after irradiation (Fig. 3e, f, and g).
Numbers of lymphocytes in blood and bone marrow
were altered after a single irradiation
The numbers of lymphocytes in peripheral blood changed
significantly after irradiation. B lymphocytes increased by
42.7% (P < 0.05) (Fig. 4a and b), CD4+ T lymphocytes de-
creased by 17.3% (P < 0.05) (Fig. 4c and d), and CD8+ T
lymphocytes increased by 57.6% (P < 0.05) (Fig. 4e and
f ) relative to controls. Similarly, the number of lym-
phocytes in bone marrow was also altered: B lympho-
cytes increased by 82.6% (P < 0.01) in contralateral
bone and by 80.7% (P < 0.01) in irradiated bone rela-
tive to controls (Fig. 5a and b). However, CD4+ T lym-
phocytes showed no significant changes between
contralateral, irradiated and control bone (Fig. 5c and
d). Meanwhile, CD8+ T lymphocytes increased slightly,
but not significantly (13.5%, P > 0.05), in contralateral
bone and increased by 40.3% (P < 0.05) in irradiated
bone (Fig. 5e and f ).
Effect of lymphocytes from irradiated rats on the
differentiation of BMSCs into osteoblasts/adipocytes in
vitro
After co-culture with lymphocytes from contralateral and
irradiated bone marrow, the potential of BMSCs to differ-
entiate into osteoblasts clearly decreased. ALP staining
showed markedly decreased ALP-positive osteoblasts in co-
cultures with lymphocytes from contralateral and irradiated
sites relative to controls, and Alizarin Red staining showed
the same trend. In contrast, Oil Red O staining showed
increased adipocytes after co-culture with lymphocytes
Fig. 3 Changes in differentiation of and relative mRNA and protein levels in BMSCs at 12 weeks after irradiation. a ALP, Alizarin Red, and Oil Red
O staining of BMSCs. b RUNX2 mRNA expression, (c) PPARγ mRNA expression, and (d) RUNX2/PPARγ ratio. Western blot image (e) and RUNX2 (f)
and PPARγ (g) protein expression levels at 12 weeks. Data are presented as the means ± standard deviations; *P < 0.05, **P < 0.01 and ***P < 0.001
(n = 6/group). ALP alkaline phosphatase, PPARγ peroxisome proliferator-activated receptor γ, RUNX2 runt-related transcription factor 2
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from irradiated rats, whether from irradiated or contralat-
eral sites (Fig. 6a). RUNX2 RNA expression decreased
significantly in BMSCs after co-culture, showing a 72.9%
(P < 0.01) reduction in co-cultures with contralateral lym-
phocytes and a 97.2% (P < 0.001) reduction in co-cultures
with irradiated lymphocytes (Fig. 6b). RUNX2 protein ex-
pression showed the same trend (Fig. 6e and f). PPARγ
RNA expression increased only slightly (Fig. 6c); however,
PPARγ protein expression was increased by 42.8% (P <
0.05) in co-cultures with lymphocytes from contralateral
sites and by 60.9% (P < 0.01) in co-cultures with lympho-
cytes from irradiated sites (Fig. 6e and g).
Discussion
Radiation-induced bone loss has always occurred in
patients who undergo radiotherapy. Our study provides
further evidence that losses in trabecular bone volume
and microstructure occur at 12 weeks post-irradiation.
Furthermore, bone loss was detected in our model at sites
outside of the field of irradiation as well as at the site of
irradiation. In view of the close relationship between the
immune and skeletal systems [17], we investigated
changes in B cells and CD4+ and CD8+ T lymphocytes
in blood and bone marrow after focal irradiation. The
results showed an increase in B lymphocytes and CD8+
Fig. 4 Lymphocytes in blood 12 weeks after irradiation detected by flow cytometry. a Flow cytometry of B lymphocytes; (b) B lymphocyte
numbers increased in blood after irradiation. c Flow cytometry of CD4+ T lymphocytes; (d) CD4+ T lymphocyte numbers decreased in blood after
irradiation. e Flow cytometry of CD8+ T lymphocytes; (f) CD8+ T lymphocyte numbers increased in blood after irradiation. Data are presented as
the means ± standard deviations; *P < 0.05 (n = 6/group)
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T lymphocytes in both blood and bone marrow and a
decrease in CD4+ T lymphocytes in blood. This
phenomenon revealed that dysregulation of immune
cells was not isolated to only irradiated areas, but ra-
ther was systemic.
Lymphocytes play a negative role in ovariectomy-
and arthritis-induced osteoporosis by producing pro-
inflammatory cytokines and receptor activator of nuclear
factor kappa-B ligand (RANKL), thereby inducing osteo-
clasts and inhibiting osteoblasts [21–23]. Additionally, T
cell expansion led to stimulation of osteoclastogenesis in
ovariectomized mice [24–26]. The crucial role of immune
organs in bone loss due to oestrogen deficiency has been
well illustrated in thymectomized mice [25], in which
bone loss induced by ovariectomy was attenuated by
thymectomy. Recent data have also shown that B cells
are the dominant producers of osteoprotegerin in the
bone microenvironment in vivo [15]. B cell knockout
mice have an osteoporotic phenotype with enhanced
osteoclastic bone resorption, and reconstitution with B
cells by adoptive transfer completely rescues mice from
the development of osteoporosis and normalizes osteopro-
tegerin production [15]. Thus, B cells are very important
for bone homeostasis. In contrast, it has been shown that
activated B cells overexpress RANKL, contributing to
bone resorption [16, 27], and that ovariectomy in mice in-
creases the number of RANKL-expressing B lymphocytes
in bone marrow [28]. A recent article showed that mice
Fig. 5 Lymphocytes in bone marrow 12 weeks after irradiation detected by flow cytometry. a Flow cytometry of B lymphocytes; (b) B
lymphocyte numbers increased in contralateral and irradiated bone. c Flow cytometry of CD4+ T lymphocytes; (d) CD4+ T lymphocyte numbers
exhibited no changes in bone marrow after irradiation. (e) Flow cytometry of CD8+ T lymphocytes; (f) CD8+ T lymphocyte numbers increased in
contralateral and irradiated bone after irradiation. Data are presented as the means ± standard deviations; *P < 0.05 and **P < 0.01 (n = 6/group)
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lacking RANKL in B cells were partially protected from
ovariectomy-induced loss of cancerous bone [29]. The role
of B lymphocytes has also been evaluated in diseases
characterized by focal bone loss, such as periodontal
inflammation [14, 30, 31] and rheumatoid arthritis [16,
32]. In rheumatoid arthritis, a recent study showed that B
cell depletion ameliorates suppressed bone turnover [29].
This research suggests that normal lymphocytes are very
important for maintaining bone homeostasis, but acti-
vated lymphocytes will lead to bone loss. However, many
of these studies focus on the activity of lymphocytes on
osteoclastogenesis. One possible reason we did not also
find an increase in osteoclastogenesis in our experiment
may be the detection time. A rapid increase in osteoclas-
togenesis has been previously reported 3 days after total-
body radiation exposure [33, 34]. However, in our study,
abnormal lymphocytes were still present throughout the
body at 12 weeks after focal irradiation, and these abnor-
mal lymphocytes were certainly involved in other patho-
logical processes. A recent study showed that acute
lymphoblastic leukaemia arising from the malignant pro-
liferation of lymphoid precursors inhibited the differenti-
ation of BMSCs into osteoblasts [35]. It has also been
reported that dexamethasone (which suppresses lympho-
cytes) increased trabecular bone tissue in normal and
ovariectomized mice, but nonsteroidal anti-inflammatory
drugs (NSAIDs) (which do not suppress lymphocytes) did
not [36]. This suggests that lymphocytes may be involved
in bone formation.
In our study, we also found that low levels of serum
OCN after focal irradiation indicated a decrease in bone
formation; meanwhile, the number of adipocytes increased
sharply in bone marrow. It is known that BMSCs can
differentiate into either osteoblasts or adipocytes by re-
spectively activating key genes such as RUNX2 or PPARγ
[37, 38]. Therefore, we evaluated RUNX2 and PPARγ
mRNA and protein levels in BMSCs after irradiation. The
results revealed a sharp decrease in RUNX2 and a signifi-
cant increase in PPARγ. Thus, radiation-induced damage
changes the balance of differentiation in BMSCs, resulting
in reduced osteogenic potential and increased adipogenic
potential [39–46]. Most importantly, these changes in
BMSCs were detected at sites outside of the field of
irradiation as well as at sites of irradiation, demonstrating
that systemic damage to BMSCs occurs after irradiation.
In view of the persistent nature of abnormal lymphocytes
in the body after focal irradiation and the negative effect
on BMSCs of lymphocytes from acute lymphoid leukae-
mia, we co-cultured lymphocytes from irradiated rats with
normal BMSCs. The co-cultured BMSCs had decreased
RUNX2 expression and increased PPARγ expression,
which upregulated the differentiation of BMSCs into
adipocytes and downregulated their differentiation into
osteoblasts. Thus, lymphocytes exerted a negative effect
on bone formation by changing the differentiation poten-
tial of BMSCs over time after focal irradiation. In our
previous study, we also tested inflammatory factors and
oxidative stress reactions at 12 weeks after irradiation; no
Fig. 6 Changes in differentiation and relative mRNA and protein levels of BMSCs after co-culture with lymphocytes from irradiated rats. a ALP,
Alizarin Red, and Oil Red O staining of co-cultured BMSCs. b RUNX2 mRNA expression, (c) PPARγ mRNA expression, and (d) RUNX2/PPARγ ratio.
Western blot image (e) and RUNX2 (f) and PPARγ (g) protein expression levels at 12 weeks. Data are presented as the means ± standard
deviations; *P < 0.05, **P < 0.01, and ***P < 0.001 (n = 6/group). ALP alkaline phosphatase, PPARγ peroxisome proliferator-activated receptor γ,
RUNX2 runt-related transcription factor 2
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obvious changes were observed, and these results are in
agreement with those of another recent report [47].
Conclusions
Focal irradiation induced local and systemic bone trabecu-
lar loss. Subsequent increases in B cells and CD8+ lym-
phocytes regulated systemic bone loss by decreasing
BMSC osteogenesis. This study also revealed the import-
ance of lymphocytes in bone homeostasis over time after
focal irradiation, which may offer new insight into the pre-
vention and treatment of bone complications in patients
who undergo radiotherapy, especially patients who require
stem cell transplantation.
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